The follicle-stimulating hormone (FSH) is released from the anterior pituitary gland. It is formed both in men and women. In women, this hormone stimulates production of eggs and in men it stimulates ...

New research suggests that hormone, follicle-stimulating hormone may be involved in decreasing bone mineral density during menopause. Diminished bone density is common among menopausal women and ...

There isn’t a single, definitive test that will diagnose menopause. However, hormonal evaluations and other tests may help rule out other possible causes of your symptoms. The beginning of the ...

Follicle-stimulating hormone (FSH) may also be involved in decreasing bone mineral density during menopause, according to new research at the Medical College of Georgia in Augusta, GA. Diminished bone ...

At 23, Kasey Mohler isn't in a hurry to have children. But two years ago, Mohler discovered she had reason to worry about her fertility. Mohler visited her gynecologist because she was having ...

Right now, hormone testing is the talk of the internet. At-home hormone tests—which can run up to $500, BTW—can check all ...

Epidemiological data have implicated the pituitary gonadotropin follicle stimulating hormone (FSH) as both a risk factor for and a protective agent against epithelial ovarian cancer. Yet, little is ...

In patients with amenorrhea and infertility, increased levels of serum luteinizing hormone and follicle-stimulating hormone are usually due to primary gonadal failure, whereas a selective increase in ...

In all, 307 TCSs treated from 1980 to 1994 provided blood samples after orchiectomy but before further treatment, at Survey I (SI; 1998-2002), and Survey II (SII; 2007-2008). Levels of sex hormones ...

Diminished bone density is common among menopausal women and raises their risk of osteoporosis, bone fractures and subsequent complications. Research has traditionally focused on therapies that seek ...